Ligand validation:2BJK

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 2BJK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2BJK_NAD_B_1517	93%	57%	0.071	0.965	0.79	0.85	1	1	8	0	100%	0.8568
2BJK_NAD_A_1517	92%	59%	0.077	0.966	0.72	0.86	-	1	9	0	100%	0.8568
2J5N_NAD_B_1518	90%	26%	0.075	0.956	1.67	1.36	3	6	0	0	100%	1
2EHU_NAD_B_2518	90%	25%	0.081	0.962	1.61	1.44	3	7	2	0	100%	1
2J40_NAD_A_1518	85%	18%	0.097	0.961	1.85	1.72	4	7	4	0	100%	1
2EII_NAD_B_2518	77%	22%	0.113	0.954	1.63	1.58	3	7	4	0	100%	0.8523
2BHP_NAD_A_1517	68%	53%	0.139	0.95	0.95	0.89	1	2	2	0	100%	0.7932
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.